| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 04/06/1999 | US5891899 Pharmaceutical xanthene compounds |
| 04/06/1999 | US5891626 Enzyme-linked analysis; using surfactant |
| 04/06/1999 | US5891464 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it |
| 04/06/1999 | US5891368 Photochromic compounds and coatings with compounds |
| 04/06/1999 | CA1340479C Indane derivatives, process for preparing the same, new intermediates produced, use thereof as therapeutic agents and pharmaceutical compositions containing them |
| 04/02/1999 | CA2246052A1 Novel hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof |
| 04/01/1999 | WO1999015523A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 04/01/1999 | WO1999015519A1 Novel aromatic substituted naphthopyrans |
| 04/01/1999 | WO1999015518A1 Photochromic naphtopyrane colorants, method for the production and use thereof, photochromic object |
| 04/01/1999 | WO1999015517A1 Sulfonated xanthene derivatives |
| 04/01/1999 | WO1999015516A1 Novel neuropeptide y receptor antagonists |
| 04/01/1999 | WO1999015129A2 SELECTIVE cPLA2 INHIBITORS |
| 04/01/1999 | WO1999001117A3 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 04/01/1999 | DE19741705A1 Photochromic indeno(2,1-f)naphtho(1,2-b)pyran compounds useful e.g. in photochromic spectacle lenses |
| 04/01/1999 | CA2304849A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 04/01/1999 | CA2304503A1 Selective cpla2 inhibitors |
| 04/01/1999 | CA2272403A1 Sulfonated xanthene derivatives |
| 03/31/1999 | EP0905131A1 Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them |
| 03/31/1999 | EP0904266A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 03/31/1999 | EP0904262A1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 03/31/1999 | EP0904079A1 Antidiabetic agents |
| 03/31/1999 | CN1212691A Tricyclic compound and its preparation and use |
| 03/31/1999 | CN1212687A 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
| 03/31/1999 | CN1212150A Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in blood to reduce risk of athereosclerosis and vascular disease |
| 03/30/1999 | US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 03/30/1999 | US5889045 Benzopyran compounds |
| 03/30/1999 | US5889044 Trans-6-acetyl-4s-(4-fluorobenzoylamino)-3,4,-dihydro-2,2-dimethyl -2h-1-benzopyran and pharmaceutical salts |
| 03/30/1999 | US5889003 Phosphodiesterase inhibitor |
| 03/30/1999 | US5888432 2-Adamantyl benzopyrans the compositions and (co)polymer matrices containing them |
| 03/30/1999 | CA2249049A1 Chromene derivatives and salts thereof, and pharmaceuticals containing the same |
| 03/26/1999 | CA2249074A1 Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them |
| 03/25/1999 | WO1999014213A1 Substituted chroman derivatives |
| 03/25/1999 | WO1999014212A1 Substituted chroman derivatives |
| 03/25/1999 | WO1999007325A8 Liver function test |
| 03/25/1999 | WO1998047505A9 Neuropeptide y receptor antagonist |
| 03/25/1999 | CA2304037A1 Substituted chroman derivatives |
| 03/25/1999 | CA2303926A1 Substituted chroman derivatives |
| 03/24/1999 | EP0903143A2 Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels |
| 03/24/1999 | EP0741693B1 Process for the preparation of arylacetic ester derivatives via palladium-catalyzed cross coupling reaction |
| 03/24/1999 | CN1211987A Camptothecin derivatives and use thereof as antimutor agents |
| 03/24/1999 | CN1211573A Method for extracting isoflavone from soybean |
| 03/23/1999 | US5886211 Reacting a 3-isochromanone with a dihalomethyl alkyl ether to obtain a reactant, then reacting the reactant with an alcohol |
| 03/23/1999 | US5886197 Process for the preparation of α-tocopherol |
| 03/23/1999 | US5886043 Antiarthritic agents, antitumor agents, antiinflammatory agents |
| 03/23/1999 | US5886028 Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse |
| 03/23/1999 | US5886024 Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors |
| 03/23/1999 | US5886021 Antiischemic agents; angina pectoris; raynaud's syndrome; centchroman, an estrogen antagonist |
| 03/23/1999 | US5885778 Using the dyes in dna analysis, dna sequence determination |
| 03/23/1999 | CA2096293C Alkene carboxylic acid derivatives, method of preparation thereof and pharmaceutical compositions containing them |
| 03/23/1999 | CA2022611C Optical resolution method for 3s-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4s-chromanol |
| 03/23/1999 | CA1340463C Alkanophenones |
| 03/18/1999 | WO1999012541A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces |
| 03/18/1999 | WO1998058911A3 Prostaglandin agonists |
| 03/18/1999 | DE19740450A1 Preparation of symmetric dialkyl ethers useful e.g. as oil component in cosmetics |
| 03/17/1999 | EP0902013A1 Novel amidine derivatives, their preparation and their use as medicaments with LTB-4 antagonistic effect |
| 03/17/1999 | EP0902003A1 Novel tetralone or benzopyranone derivatives and process for producing the same |
| 03/17/1999 | EP0901483A2 Benzofurans and benzopyrans as chronobiological agents |
| 03/17/1999 | EP0901469A1 Arylalkylpiperazine compounds as antioxidants |
| 03/17/1999 | EP0716746B1 Fluorescent oxygen channeling immunoassays |
| 03/17/1999 | EP0678087B1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
| 03/17/1999 | EP0619817B1 Novel pharmaceutically active flavilium compounds |
| 03/17/1999 | CN1211243A Method of producing DL-alpha-tocopherol or DL-alpha-tocopherol acetate |
| 03/16/1999 | US5883270 4-substituted-1, 2-naphthoquinones and their use in the inhibition of neoplastic cell growth |
| 03/16/1999 | US5883118 Anticarcinogenic agents |
| 03/10/1999 | EP0900237A1 Photoactive compounds for use with narrow wavelength band ultraviolet (uv) curing systems |
| 03/10/1999 | EP0900230A2 Esculetin derivatives |
| 03/09/1999 | US5880287 Polyoxyhydrocarbyl related products and methods for fluorescence assays |
| 03/09/1999 | US5879837 Styrylcoumarin compound, photosensitive resin composition, and hologram recording medium |
| 03/09/1999 | US5879681 Compounds and compositions for delivering active agents |
| 03/09/1999 | US5879592 Water soluble photochromic compounds, compositions and optical elements comprising the compounds |
| 03/09/1999 | CA2038610C Process and intermediates for 2r-benzyl-chroman-6-carbaldehyde |
| 03/09/1999 | CA1340430C Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof |
| 03/04/1999 | WO1999010335A1 Process for preparing 3-isochromanone |
| 03/04/1999 | WO1999010292A2 Robustaflavone, intermediates and analogues and method for preparation thereof |
| 03/03/1999 | EP0805993A4 Photochromic substituted naphthopyran compounds |
| 03/03/1999 | EP0792468A4 Novel photochromic indeno-fused naphthopyrans |
| 03/03/1999 | EP0731791B1 benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 03/03/1999 | CN1209803A Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method therefor |
| 03/03/1999 | CN1209802A Synthesis and use of retinene derivative having negative hormone and/or antagonist activities |
| 03/03/1999 | CN1042328C Substituted cyclohexane derivative and medicine containing same |
| 03/02/1999 | US5877317 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders |
| 03/02/1999 | US5877208 Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor |
| 03/02/1999 | US5877207 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/1999 | US5877206 Methods for inhibiting topoisomerase using procyanidin oligomers |
| 03/02/1999 | US5877185 Therapy for cancer or retrovirus |
| 03/02/1999 | US5877030 Process for creating molecular diversity and novel protease inhibitors produced thereby |
| 03/02/1999 | US5876710 Drug delivery; using a brominated benzamide compound |
| 03/02/1999 | US5876703 Flavanonol derivatives and hair-nourishing, hair-growing compositions containing the derivatives |
| 03/02/1999 | CA2175458C Novel benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 02/25/1999 | WO1999008992A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 02/23/1999 | US5874591 Method for the preparation of (±)-calanolide A and intermediates thereof |
| 02/23/1999 | US5874473 Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors |
| 02/23/1999 | US5874461 Use of Nebivolol as an anti-atherogenic |
| 02/23/1999 | US5874446 Antiasthmatics, antiepilepsy agents |
| 02/18/1999 | WO1999007325A1 Liver function test |
| 02/18/1999 | WO1998029108A3 Compositions and methods for restoring a normal pattern of imprinting to cells |
| 02/16/1999 | US5872265 Method for preparing coumarin and derivatives thereof |
| 02/16/1999 | US5872264 (+)-calanolide A and analogues thereof |
| 02/16/1999 | US5872148 Compositions useful as a cannabinoid receptor probe |
| 02/16/1999 | US5872118 Relaxation of skeletal muscle in spastic, hypertonic and hyperkinetic conditions |